ArticleExperimental hematology & oncology2015

Impact of TET2, SRSF2, ASXL1 and SETBP1 mutations on survival of patients with chronic myelomonocytic leukemia.

Yajuan Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.